Kamal Sud

Kamal Sud is a Clinical Associate Professor at the Nepean Clinical School, University of Sydney. His expertise lies in nephrology with a focus on kidney disease management, peritoneal dialysis outcomes, and infection control in dialysis patients. He collaborates extensively with multidisciplinary teams on clinical trials and telehealth innovations.

Research Interests: Dr. Sud’s work emphasizes improving dialysis modalities, optimizing antibiotic use in peritoneal dialysis-associated infections, and enhancing health literacy for chronic kidney disease patients. He has contributed to studies on medication adherence, sick day management protocols, and the long-term consequences of acute kidney injury. His research often integrates clinical case analysis with population-level data from national registries.

• Published in prominent journals like Nephrology Dialysis Transplantation, Kidney Medicine, and Clinical Kidney Journal.
• Key areas include peritoneal dialysis technique survival, peritonitis risk factors, and interventions for ethnic-minority patient groups.

Scientific Contributions: His work spans over two decades, with notable contributions to understanding renal stone management, anticoagulation strategies in end-stage kidney disease, and the role of telehealth systems in home hemodialysis monitoring. He is involved in large-scale studies like the PREVENT-ADPKD trial assessing water intake effects and the SUCCESS health literacy app project.

Advising & Grants: Currently supervising Mimi Truong’s research on sick day medication management. Collaborates on grants addressing dialysis modality comparisons, health literacy barriers, and dietary interventions in polycystic kidney disease. Leads multidisciplinary initiatives in telehealth and registry-based outcomes research.

Labs/Teams: Engaged with research teams focused on dialysis innovations, transplantation medicine, and chronic kidney disease management at the Nepean Clinical School and affiliated institutions. His work often intersects with clinical pharmacology and public health departments.